Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits Signaling.

Knight B, Tammara B, Modi NB, Dallas S, Mardirosian S, Wang J, Laenen A, Leclercq L, DiLoreto K, Adriaenssen L, Moss D, Polidori D, Chaudhuri SR, Park S, Sensenhauser C, Ndifor A, Sukumaran S, Baguet T, Shi Y, Patel S, Geist B, Fourie A, Patch R, Sun C, Barros SA, Somani S, Monshouwer M

Open source

DOI: 10.1007/s13555-025-01454-7
Published: 2025 Sep
Container: Dermatology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-025-01454-7,
  title = {Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits Signaling.},
  author = {Knight B and Tammara B and Modi NB and Dallas S and Mardirosian S and Wang J and Laenen A and Leclercq L and DiLoreto K and Adriaenssen L and Moss D and Polidori D and Chaudhuri SR and Park S and Sensenhauser C and Ndifor A and Sukumaran S and Baguet T and Shi Y and Patel S and Geist B and Fourie A and Patch R and Sun C and Barros SA and Somani S and Monshouwer M},
  year = {2025},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-025-01454-7},
  url = {https://doi.org/10.1007/s13555-025-01454-7}
}

RIS

TY  - JOUR
TI  - Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits Signaling.
AU  - Knight B
AU  - Tammara B
AU  - Modi NB
AU  - Dallas S
AU  - Mardirosian S
AU  - Wang J
AU  - Laenen A
AU  - Leclercq L
AU  - DiLoreto K
AU  - Adriaenssen L
AU  - Moss D
AU  - Polidori D
AU  - Chaudhuri SR
AU  - Park S
AU  - Sensenhauser C
AU  - Ndifor A
AU  - Sukumaran S
AU  - Baguet T
AU  - Shi Y
AU  - Patel S
AU  - Geist B
AU  - Fourie A
AU  - Patch R
AU  - Sun C
AU  - Barros SA
AU  - Somani S
AU  - Monshouwer M
PY  - 2025
JO  - Dermatology and therapy
DO  - 10.1007/s13555-025-01454-7
UR  - https://doi.org/10.1007/s13555-025-01454-7
ER  -

APA

B, K., B, T., NB, M., S, D., S, M., J, W., A, L., L, L., K, D., L, A., D, M., D, P., SR, C., S, P., C, S., A, N., S, S., T, B., Y, S., S, P., B, G., A, F., R, P., C, S., SA, B., S, S., & M, M. (2025). Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits Signaling.. Dermatology and therapy. https://doi.org/10.1007/s13555-025-01454-7

Source records

pubmed · retrieved 2026-09-26T21:02:21.514Z